HAILEY BARRON: Open Payments
NPI 1235834920 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,010 in 107 payments from 32 companies in 2025. Trend: 2023 $1,041 · 2024 $2,951 · 2025 $3,010
Food & beverage: $2,339Education: $671
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $294 |
| Daiichi Sankyo Inc. | 8 | $273 |
| Incyte Corporation | 6 | $187 |
| Novartis Pharmaceuticals Corporation | 10 | $176 |
| ABBVIE INC. | 10 | $169 |
| Lilly USA, LLC | 4 | $166 |
| Merck Sharp & Dohme LLC | 8 | $162 |
| Janssen Biotech, Inc. | 9 | $153 |
| Gilead Sciences, Inc. | 2 | $148 |
| Geron Corporation | 2 | $126 |
Products named: Enhertu, SARCLISA, KEYTRUDA, Trodelvy, RYTELO, IMBRUVICA, WAYRILZ, CARVYKTI.
Industry payments across MO — which companies pay providers there.
